The Role of Pioglitazone in Vascular Transcriptional Remodeling
NCT05775380
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Myocardial Reperfusion Injury
Interventions
DRUG:
Pioglitazone 45 mg
Sponsor
University of Campinas, Brazil